Skip to main content
Donate
Events

Europe/UK Angelman Syndrome Phase 3 Clinical Trial Webinar

Virtual • 20:00 CEST |

Location

Virtual • 20:00 CEST

Visit Website

Date

Thu, September 4 • 2025

Join the Foundation for Angelman Syndrome Therapeutics (FAST) and the Angelman Syndrome Alliance (ASA) for a live webinar focused on Phase 3 clinical trials in Europe and the UK - for Europe & UK residents only.

Representatives from Ionis and Ultragenyx will share details about their trials, including: 

  • Clinical trial design 

  • Inclusion and exclusion criteria 

  • Locations of trial sites across Europe and the UK 

  • What steps families can take if interested in participating 

Add to your calendar today.

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.